Paragon Capital Management (Utah)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,232
Closed -$503K 76
2022
Q3
$503K Buy
2,232
+39
+2% +$9.45K 0.49% 58
2022
Q2
$534K Buy
+2,193
New +$537K 0.54% 56

Other funds holding AMGN

Paragon Capital Management (Utah)'s AMGN Position: Q4 2022 in Review

Paragon Capital Management (Utah) sold out of Amgen (AMGN) in Q4 2022, closing a stake of 2,232 shares — an estimated $503K sold.

Paragon Capital Management (Utah) first reported a position in AMGN in Q2 2022 and held it in 2 quarters. The position peaked at $534K in Q2 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Paragon Capital Management (Utah) reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 2,232 Amgen shares in Q4 2022, an estimated $503K.
  • Paragon Capital Management (Utah) first reported a position in Amgen in Q2 2022 and held it in 2 quarters.
  • Paragon Capital Management (Utah)'s Amgen position peaked at $534K in Q2 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Paragon Capital Management (Utah)'s 13F filing for Q4 2022, filed 25 Sep 2024.